Lauren Poole/LinkedIn
Jan 1, 2026, 00:01
NIH R35 Grant Supports Dr. Lauren Poole’s Research on Fibrinogen and Immune Responses
NIEHS P30 Center for Environmental Exposures and Diseases sharede a post on LinkedIn:
“Congratulations to CEED member Dr. Lauren Poole for her recently awarded R35 grant from NIH/NIGMS! Her team will study fibrinogen – an abundant plasma protein and acute phase reactant – and how it interacts with leukocytes to direct inflammatory responses and disease. They are using novel in vivo and in vitro approaches to understand the fundamental processes regulating the expression and pro-inflammatory functions of fibrinogen, laying the foundation for safe and specific therapies targeting fibrinogen.”
Explore more posts for deeper insights into hemostasis with Hemostasis Today.
-
Apr 3, 2026, 05:59Nathan Connell: How the 2021 VWD Guidelines Are Actually Changing Real – World Practice
-
Apr 3, 2026, 05:28Tareq Abadl: How Iron Profile Reveals Hidden Insights about Blood Health and Iron Balance
-
Apr 3, 2026, 04:49Niraj Sharma: Breaking News Special Edition, CHAMPION-AF, CLOSURE-AF, PRAGUE-17, and Why LAAC Still Does Not Dethrone Contemporary Anticoagulation
-
Apr 2, 2026, 18:32Niyas Khalid: A Rare Case of Venous Ischemic Pancreatitis Redefining Diagnosis
-
Apr 2, 2026, 18:16Saravanan Subramaniam: How Extracellular Histones Act as Key Drivers of Thromboinflammation
-
Apr 2, 2026, 18:06Rob Molhoek Brings Invaluable Insights on Stroke Awareness and Care Improvements – Stroke Foundation
-
Apr 2, 2026, 17:21Paul Bolaji: Phase 2 of the Nigeria National Stroke Registry Is Now Live
-
Apr 2, 2026, 17:13Catherine Jennings: Marking Today as an Important Step Forward for Patients With PE
-
Apr 2, 2026, 17:11Arun V. J: Our Clinical Audit on Transfusion Safety Selected for Presentation at CAHOCON 2026